Cytotheryx, Inc.

About Cytotheryx, Inc.

Cytotheryx, Inc. is dedicated to creating a future without liver disease by developing platform technology that enables the production of human liver cells (hepatocytes) in unprecedented quantity and quality. Their mission focuses on addressing the significant need for functional liver cells to support breakthroughs in treatments, cures, and therapies for liver-related conditions.

Products & Services

Bio-Incubator:A technology that expands liver cells up to 1000x, providing greater quantity for medical and research applications.

Liver Assist Device:A device designed to support liver function, contributing to therapeutic solutions for liver diseases.

Allogeneic Hepatocytes (Patent-pending):Pure primary hepatocytes ready for use, offering high quality and scalability to meet demand for research and treatment.

Bio-Incubator

Liver Assist Device

Allogeneic Hepatocytes

Specialties

Liver cell production Hepatocyte technology Liver disease treatment Bio-incubation Scalable cell therapies Primary hepatocytes Cell expansion up to 1000x Scalable liver cell production

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 60000000 MR: - FA: 60 million FAN: 60000000	D: 2026-01-16 FD: 2026-01-16	1 investors
2	RT: Series A T: - FT: Series A	A: 60000000 MR: - FA: $60 million FAN: 60000000	D: 2026-01-12 FD: 2026-01-12	2 investors

Series A Latest

2026-01-16

$60.0M

1 investor (Pro only)

Series A 2026-01-12

$60.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Anna K. Argo

Chief Business Officer

B

Benazir Kerezoudis

Director of Regulatory Affairs and Quality Assurance

R

Ryan Schulze

Chief Scientific Officer

C

Craig Siiro

fractional Chief Financial Ofﬁcer

J

John R. Swart

CEO

S

Sam Wiegand

Director of Facilities and Quality Improvement

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Cytotheryx, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised